Private equity firm Cinven Ltd. expects to make up to four acquisitions in 2013 after raising €5 billion ($6.5 billion) for its fifth buyout fund.

So far, the fifth fund is 14 percent committed, following four investments in 2012. Those deals include two security companies, Pronet and Prezioso Technilor SAS, for an undisclosed price, as well as Mercury Pharma Group Ltd. for $732 million and Amdipharm plc for $589.7 million.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.